Immune reactions after DMEK, DSAEK and DALK;Immunreaktionen nach DMEK, DSAEK und DALK

Klinische Monatsblatter fur Augenheilkunde

Volumn 230, Issue 5, 2013, Pages 494-499

  Steven, P ^a   Hos, D ^a   Heindl, L M ^a   Bock, F ^a   Cursiefen, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

cornea; DALK; DMEK; DSAEK; immune reactions; pathology; pharmacology

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CONGENITAL CORNEA DYSTROPHY; DEEP ANTERIOR LAMELLAR KERATOPLASTY; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL IMMUNE REACTION; GRAFT RECIPIENT; IMMUNE DYSREGULATION; INCIDENCE; KERATOCONUS; KERATOPLASTY; MEDLINE; RISK REDUCTION; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE;

COMORBIDITY; CORNEAL DISEASES; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; GRAFT REJECTION; HUMANS; IMMUNE SYSTEM DISEASES; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS;

EID: 84878139682     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0032-1328257     Document Type: Article

References (26)

1. Reimer A., Langenbucher A., Cursiefen C. [Long-Term Outcome after Penetrating Keratoplasty for Bullous Keratopathy - Influence of Preoperative Visual Acuity on Final Outcome]. Klin Monatsbl Augenheilkd: 2012; 229 149 157
2. Nguyen N. X., Seitz B., Martus P. et al. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol: 2007; 144 318 319 (Pubitemid 47094708)
3. Cursiefen C., Kruse F. E. Erlanger DSAEK Gruppe [Descemets stripping automated endothelial keratoplasty (DSAEK)]. Ophthalmologe: 2009; 106 939 952
4. Pogorelov P., Cursiefen C., Bachmann B. O. et al. Changes in donor corneal lenticule thickness after Descemets stripping automated endothelial keratoplasty (DSAEK) with organ-cultured corneas. Br J Ophthalmol: 2009; 93 825 829
5. Cursiefen C., Kruse F. E. [DMEK: Descemet membrane endothelial keratoplasty]. Ophthalmologe: 2010; 107 370 376
6. Tourtas T., Laaser K., Bachmann B. O. et al. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol: 2012; 153 1082 1090
7. Melles G. R., Ong T. S., Ververs B. et al. Descemet membrane endothelial keratoplasty (DMEK). Cornea: 2006; 25 987 990 (Pubitemid 44763867)
8. Heindl L. M., Riss S., Laaser K. et al. Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol: 2011; 152 523 532
9. Heindl L. M., Riss S., Bachmann B. O. et al. Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology: 2011; 118 294 301
10. Khodadoust A. A., Silverstein A. M. Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol: 1969; 8 180 195
11. Price M. O., Jordan C. S., Moore G. et al. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol: 2009; 93 391 395
12. Saelens I. E., Bleyen I., Bartels M. C. et al. A posterior khodadoust line in a graft rejection episode after descemet stripping automated endothelial keratoplasty. Cornea: 2011; 30 245 246
13. Cursiefen C., Heindl L., Bachmann B. et al. Immune rejection after isolated transplantation of Descemets Membrane and Endothelium (DMEK). ARVO: 2011; 1155/D937
14. Jordan C. S., Price M. O., Trespalacios R. et al. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br J Ophthalmol: 2009; 93 387 390
15. Cursiefen C., Heindl L. M. Perspectives of deep anterior lamellar keratoplasty. Ophthalmologe: 2011; 108 833 839
16. Riss S., Heindl L. M., Bachmann B. O. et al. Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea: 2012; 31 627 632
17. Riss S., Heindl L. M., Bachmann B. O. et al. Microbubble incision as a new rescue technique for big-bubble deep anterior lamellar keratoplasty with failed bubble formation. Cornea: 2013; 32 125 129
18. Reinhart W. J., Musch D. C., Jacobs D. S. et al. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology. Ophthalmology: 2011; 118 209 218
19. Heindl L. M., Cursiefen C. [Split-cornea transplantation-a novel concept to reduce corneal donor shortage]. Klin Monatsbl Augenheilkd: 2012; 229 608 614
20. Shimazaki J., Iseda A., Satake Y. et al. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial. Ophthalmology: 2012; 119 668 673
21. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy: 2007; 92 50 57 (Pubitemid 47096896)
22. Hos D., Saban D. R., Bock F. et al. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol: 2011; 129 445 452
23. Steven P., Bock F., Hüttmann G. et al. Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PLoS One: 2011; 6 e26253
24. Dietrich T., Bock F., Yuen D. et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol: 2010; 184 535 539
25. Nguyen N. X., Seitz B., Langenbucher A. et al. [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty]. Klin Monatsbl Augenheilkd: 2004; 221 467 472 (Pubitemid 38917782)
26. Anshu A., Price M. O., Price F. W. Jr. Risk of corneal transplant rejection significantly reduced with Descemets membrane endothelial keratoplasty. Ophthalmology: 2012; 119 536 540